Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm

31 Jan 2011

Abstract excerpt

The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to CNS Lymphoma Diagnosis and Treatment
Share to Cutaneous lymphoproliferative disorders research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21275969
DOI: 10.1111/j.1365-2141.2010.08556.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasmPMID 21275969Read ↗

TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasmSemantic proximity Read ↗

Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations.Semantic proximity Read ↗

Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.Semantic proximity Read ↗

Genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A single institution experience.Semantic proximity Read ↗

Blastic plasmacytoid dendritic cell neoplasm with genetic mutations in multiple epigenetic modifiers: a case report.Semantic proximity Read ↗

TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.Semantic proximity Read ↗

Cutaneous blastic plasmacytoid dendritic cell neoplasm arising in the context of TET2 and ZRSR2 mutated clonal cytopenias of unknown significance, secondary to somatic copy number losses involving CDK2NA/2NB and MTAP.Semantic proximity Read ↗

Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN).Semantic proximity Read ↗

Blastic Plasmacytoid Dendritic Cell Neoplasm With De Novo TET2 and KDM6A Mutations.Semantic proximity Read ↗

[TET2 dysregulation in hematologic malignancies].Semantic proximity Read ↗

Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasmSemantic proximity Read ↗

Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.